Maintenance low-dose chemotherapy in patients with high-risk (HR) rhabdomyosarcoma (RMS): A report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

被引：28

作者：

Bisogno, Gianni

De Salvo, Gian Luca

Bergeron, Christophe

Jenney, Meriel

Merks, Johannes H. M.

Minard-Colin, Veronique

Orbach, Daniel

Glosli, Heidi

Chisholm, Julia

Casanova, Michela

Melcon, Soledad Gallego

Ferrari, Andrea

机构：

[1] Univ Hosp Padova, Dept Women & Children Hlth, Padua, Italy

[2] Veneto Inst Oncol IRCCS, Clin Trials & Biostat Unit, Padua, Italy

[3] Ctr Leon Berard, Inst Hematol & Oncol Pediat, Lyon, France

[4] Childrens Hosp Wales, Dept Paediat Oncol, Cardiff, S Glam, Wales

[5] Emma Childrens Hosp, Acad Med Ctr EKZ AMC, Amsterdam, Netherlands

[6] Gustave Roussy, Villejuif, France

[7] Inst Curie, Paris, France

[8] Oslo Univ Hosp, Dept Paediat & Adolescent Med, Oslo, Norway

[9] Royal Marsden NHS Fdn Trust, Children & Young Peoples Unit, Sutton, Surrey, England

[10] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[11] Univ Hosp Vall dHebron, Barcelona, Spain

[12] Ist Nazl Studio & Cura Tumori IRCCS, Milan, Italy

来源：

关键词：

D O I：

10.1200/JCO.2018.36.18_suppl.LBA2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA2

引用

页数：1